PMID- 28982865 OWN - NLM STAT- MEDLINE DCOM- 20171016 LR - 20220410 IS - 1791-7530 (Electronic) IS - 0250-7005 (Linking) VI - 37 IP - 10 DP - 2017 Oct TI - Deregulation of PTEN Expression in Laryngeal Squamous Cell Carcinoma Based on Tissue Microarray Digital Analysis. PG - 5521-5524 AB - BACKGROUND/AIM: Phosphatase and tensin homolog (PTEN) (gene locus: 10q23.3) -a tumor suppressor gene- is deleted, mutated or epigenetically hyper-methylated in a variety of malignancies. PTEN acts as a negative regulator in PI3K/AKT/mTOR signaling transduction pathway. Our aim was to investigate PTEN protein expression patterns in laryngeal squamous cell carcinomas (LSCC). MATERIALS AND METHODS: Using tissue microarray technology, fifty (n=50) primary LSCCs were cored and re-embedded into one recipient block. Immunohistochemistry and digital image analysis were implemented for evaluating protein expression levels. RESULTS: Abnormal protein expression (low to negative staining intensity values) was observed in 28/50 (56%) tissue cores. Overall PTEN expression was associated with the anatomical region of the malignancies (p=0.039), whereas a borderline correlation with the differentiation grade was also assessed (p=0.05). CONCLUSION: Aberrant expression of PTEN tumor-suppressor gene in LSCCs seems to affect their biological behavior. Well-differentiated tumors express moderate to high protein levels, an evidence of normal gene function, whereas loss of its expression correlates with a progressive tumor dedifferentiation. Additionally, loss of its expression is detected more frequently in specific anatomical regions of the larynx (glottis, predominantly, and partially supraglottis). CI - Copyright(c) 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved. FAU - Mastronikolis, Nicholas S AU - Mastronikolis NS AD - ENT Department, Medical School, University of Patras, Patras, Greece. FAU - Tsiambas, Evangelos AU - Tsiambas E AD - Department of Immunohistochemistry & Molecular Biology, 401 GAH, Athens, Greece tsiambasecyto@yahoo.gr. FAU - Papadas, Theodoros A AU - Papadas TA AD - ENT Department, Medical School, University of Patras, Patras, Greece. FAU - Karameris, Andreas AU - Karameris A AD - Department of Pathology, 417 VA Hospital, Athens, Greece. FAU - Ragos, Vasileios AU - Ragos V AD - Department of Maxillofacial, Medical School, University of Ioannina, Ioannina, Greece. FAU - Peschos, Dimitrios AU - Peschos D AD - Department of Physiology, Medical School, University of Ioannina, Ioannina, Greece. FAU - Mastronikolis, Stylianos N AU - Mastronikolis SN AD - Department of Medicine, School of Health Sciences, University of Crete, Heraklion, Greece. FAU - Papadas, Athanasios T AU - Papadas AT AD - Department of Hematology and Oncology, University of Wisconsin-Madison School of Medicine, Madison, WI, U.S.A. FAU - Liatsos, Christos AU - Liatsos C AD - Department of Gastroenterology, 401 GAH, Athens, Greece. FAU - Armata, Ilianna E AU - Armata IE AD - Medical School, St. George's, University of London medical programme, University of Nicosia, Nicosia, Cyprus. FAU - Fotiades, Panagiotis P AU - Fotiades PP AD - Department of Surgery, Leicester General Hospital, Leicester, U.K. LA - eng PT - Journal Article PL - Greece TA - Anticancer Res JT - Anticancer research JID - 8102988 RN - 0 (Biomarkers, Tumor) RN - EC 3.1.3.67 (PTEN Phosphohydrolase) RN - EC 3.1.3.67 (PTEN protein, human) SB - IM MH - Biomarkers, Tumor/*analysis MH - Carcinoma, Squamous Cell/*enzymology/pathology MH - Cell Dedifferentiation MH - Down-Regulation MH - Female MH - Head and Neck Neoplasms/*enzymology/pathology MH - Humans MH - Immunohistochemistry MH - Laryngeal Neoplasms/*enzymology/pathology MH - Male MH - Neoplasm Grading MH - PTEN Phosphohydrolase/*analysis MH - Squamous Cell Carcinoma of Head and Neck MH - Tissue Array Analysis OTO - NOTNLM OT - PTEN OT - Squamous cell carcinoma OT - larynx OT - microarrays EDAT- 2017/10/07 06:00 MHDA- 2017/10/17 06:00 CRDT- 2017/10/07 06:00 PHST- 2017/09/03 00:00 [received] PHST- 2017/09/11 00:00 [revised] PHST- 2017/09/19 00:00 [accepted] PHST- 2017/10/07 06:00 [entrez] PHST- 2017/10/07 06:00 [pubmed] PHST- 2017/10/17 06:00 [medline] AID - 37/10/5521 [pii] AID - 10.21873/anticanres.11983 [doi] PST - ppublish SO - Anticancer Res. 2017 Oct;37(10):5521-5524. doi: 10.21873/anticanres.11983.